Home Health A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
Health

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
Key Points

Daraxonrasib, a newly approved treatment for pancreatic cancer made by Revolution Medicines.

Daraxonrasib, a newly approved treatment for pancreatic cancer made by Revolution Medicines.
Revolution Medicines (ORG)
Originally published by NYT Business Read original →